PCI logo from eps file.jpg
PCI Biotech: Successful Phase I fimaVacc vaccination proof of concept study to be published in Frontiers in Immunology
November 23, 2020 02:30 ET | PCI Biotech Holding ASA
Oslo (Norway), 23 November 2020 – PCI Biotech (OSE: PCIB), a cancer focused biopharmaceutical company, today announced that the results from the successful Phase I proof of concept study for the...
PCI logo from eps file.jpg
PCI Biotech: European patent for treatment of bile duct cancer with the fimaChem technology
November 16, 2020 02:30 ET | PCI Biotech Holding ASA
Oslo (Norway), 16 November 2020 – PCI Biotech (OSE: PCIB), a cancer focused biopharmaceutical company, today announces that the European Patent Office (EPO) has informed the company that a new...
PCI logo from eps file.jpg
PCI Biotech third quarter 2020 results
November 11, 2020 01:00 ET | PCI Biotech Holding ASA
Oslo (Norway), 11 November 2020 – PCI Biotech (OSE: PCIB), a cancer focused biopharmaceutical company, today announces its interim Q3 2020 results. Please find enclosed the report and presentation. ...
logo.jpg
PCI Biotech: Invitation to third quarter 2020 results presentation
November 04, 2020 03:15 ET | PCI Biotech Holding ASA
Oslo, Norway, 4 November 2020 - PCI Biotech’s (OSE: PCIB) third quarter 2020 interim report will be released on 11 November 2020 at 07.00 CET. The interim report and presentation will be made...
logo.jpg
PCI Biotech: First patient enrolled in Asia in the fimaCHEM pivotal RELEASE study
October 26, 2020 07:48 ET | PCI Biotech Holding ASA
Oslo (Norway), 26 October 2020 – PCI Biotech (OSE: PCIB), a clinical-stage biopharma company developing innovative therapeutics that address significant unmet medical needs in cancer today announced...
logo.jpg
PCI Biotech: Preclinical research collaboration with big pharma ended
October 21, 2020 02:30 ET | PCI Biotech Holding ASA
Oslo (Norway), 21 October 2020 – PCI Biotech (OSE: PCIB), a cancer focused biopharmaceutical company, today informed that AstraZeneca has elected not to enter into a definitive agreement for the...
logo.jpg
PCI Biotech: Employee share option scheme
October 06, 2020 09:02 ET | PCI Biotech Holding ASA
Oslo, 06 October 2020   In accordance with the authorisation granted by the Annual General Meeting 27 May 2020, the Board of Directors of PCI Biotech Holding ASA has awarded a total of 540,000 share...
logo.jpg
PCI Biotech: Capital increase registered and listing of new shares
September 08, 2020 06:00 ET | PCI Biotech Holding ASA
Oslo, Norway, 8 September 2020. Reference is made to the previous announcements by PCI Biotech Holding ASA ("PCI Biotech" or the "Company") in respect of the issuance of 60,500 new shares following...
logo.jpg
PCI Biotech: Exercise of employee share options, mandatory notification of trade and resolution to increase share capital
September 02, 2020 12:14 ET | PCI Biotech Holding ASA
Oslo (Norway), 2 September 2020 – Exercise of employee share options, mandatory notification of trade and resolution to increase the share capital in PCI Biotech Holding ASA (the “Company”). 1.  ...
logo.jpg
PCI Biotech announce a research collaboration with DCprime to explore novel cancer vaccination concepts
September 01, 2020 03:00 ET | PCI Biotech Holding ASA
Oslo (Norway), 1 September 2020 – PCI Biotech (OSE: PCIB), a cancer focused biopharmaceutical company with a unique intracellular delivery technology via PhotoChemical Internalisation and DCprime, the...